Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis

NCT04709575 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Conjunctivitis

Interventions

DRUG: REGN5713
DRUG: REGN5714
DRUG: REGN5715
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals